LL-37 5mg peptide

LL-37 – 5mg Research Peptide

What Is LL-37?

LL-37 is a human cathelicidin-derived antimicrobial peptide researched for its role in innate immune response, host defense mechanisms, and inflammation-related signaling pathways. In laboratory environments, LL-37 is studied for its interaction with microbial membranes as well as its regulatory effects on immune cell activity.

LL-37 – 5mg peptide is supplied strictly for laboratory and scientific research purposes only and is not intended for human or veterinary use.

---

Research Applications of LL-37

In controlled laboratory studies, LL-37 is researched for its involvement in:

• Innate immunity and antimicrobial defense research

• Immune modulation and inflammatory signaling studies

• Wound healing and tissue repair research models

• Host–pathogen interaction investigations

• Cell signaling and membrane interaction research

Its broad biological activity makes LL-37 a valuable compound in immunological and infection-related research.

---

Cathelicidin-Derived Peptide (Research Context)

As the only human cathelicidin peptide, LL-37 is studied for its dual role in direct antimicrobial activity and immune signaling modulation, allowing researchers to evaluate both protective and regulatory responses in experimental systems.

---

Product Specifications

• Compound Name: LL-37 (Cathelicidin)

• Quantity: 5mg

• Purity: ≥99% (HPLC tested)

• Form: Lyophilized powder

• Category: Research peptide

• Storage: Refrigerate after reconstitution

• Intended Use: Laboratory research only

---

Quality Assurance

Each batch of LL-37 undergoes independent laboratory testing to confirm purity, identity, and stability. Certificates of Analysis (COA) are available upon request to ensure reliability and reproducibility in research applications.

---

Compliance Disclaimer

This product is not a pharmaceutical drug, not a dietary supplement, and not approved for human consumption.
LL-37 – 5mg is sold exclusively for laboratory research purposes in compliance with applicable regulations in the USA, UK, Europe, and Canada.